InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Lunger John, Directeur de l'Approvisionnement des Patients. Officer active across 1 company, notably Adaptimmune Therapeutics PLC. Cumulatively, 15 filings have been logged. Breakdown: 0 buy · 15 sells. Total volume traded: €82k. History available since 2 July 2021. The latest transaction was disclosed on 17 January 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lunger John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
5,584 shares@ US$0.58082.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-25-004607:0
4,268 shares@ US$0.58791.9% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-25-003768:0
4,681 shares@ US$0.792.7% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-24-004562:0
4,009 shares@ US$0.83672.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-24-003744:0
3,096 shares@ US$0.90562.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-086416:0
4,440 shares@ US$1.8586.1% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-004382:0
3,843 shares@ US$1.74685.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-003538:0
1,100 shares@ US$1.6941.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-23-001090:0
2,983 shares@ US$1.77354.1% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-084894:0
1,973 shares@ US$1.67812.6% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-077470:0
4,368 shares@ US$3.191814.9% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-005055:0
3,770 shares@ US$3.556714.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-004152:0
1,070 shares@ US$4.06424.7% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-22-001670:0
2,939 shares@ US$3.584810.8% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-21-098959:0
1,907 shares@ US$4.26498.3% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-21-089048:0
15 of 15 declarations
About Lunger John
Lunger John is Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (XNAS). He has 15 filings in total, and within the 15 sampled filings the transactions are sales, totaling EUR 82236, over the period from 2021-07-02 to 2025-01-17.
